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Abstract 
Novel azabicyclic β-amino acid derivatives were readily prepared from diexo or diendo 
norbornene β-amino acids. The 3-azabicyclo[3.2.1]octane skeleton was obtained by NaIO4-
mediated cleavage of the dihydroxylated β-amino ester intermediates, followed by reductive 
amination. Lipase-catalyzed enantioselective ring opening of racemic exo-norbornene β-lactam 
allowed preparation of the corresponding azabicyclic exo β-amino acid in enantiopure form.  
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Introduction 
 
Because of their importance in synthetic and medicinal chemistry and in peptide research, 
conformationally rigid, alicyclic β-amino acids have been subject to considerable interest during 
the past 20 years1. N-Heterocyclic β-amino acids have also attracted attention in view of their 
biological properties and their applications in peptide synthesis.2 Bicyclic α- or β-amino acids in 
which the N atom of the amino function is part of the ring system are a class of compounds of 
appreciable importance. Thus, bicyclic α-amino acids with the N atom in the ring system, such as 
7-azabicyclo[2.2.1]heptane-1-carboxylic acid, its derivatives and compounds with an 8-
azabicyclo[3.2.1]octane skeleton are conformationally restricted analogs of proline, 
hydroxyprolines and related proline derivatives.3,4 7-Azabicyclo[2.2.1]heptane-2-carboxylic acid 
β-amino acids key compounds in novel β-peptide syntheses,5 were recently reported to behave as 
conformationally restricted proline analogs, acting as efficient catalysts in organocatalytic aldol 
processes6 Moreover, both bicyclic α- and β-amino acids with the N atom in the ring system  
serve as key precursors for the synthesis of medicinally valuable alkaloids such as anatoxin-a,7 
epibatidine, epiboxidine etc.8 A number of pharmacologically active 3-azabicyclo[3.2.1]octanes 
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have been reported as bioactive molecules,9 the most important of them probably being those 
with an amino or carboxyl function in their structure. 3-Azabicyclo[3.2.1]octane α-amino acids 
were recently synthetized in enantiomerically pure form,9a Because of the importance of the 
conformationally constrained alicyclic or heterocyclic β-amino acids, our work was directed 
toward the synthesis of novel 3-azabicyclo[3.2.1]octane skeleton β-amino acids. 
 
 
Results and Discussion 
 
The synthetic route applied for the preparation of these azabicyclic β-amino esters is based on a 
simple method used for the synthesis of piperidine and azepane β-amino carboxylates.2a,b The 
starting compounds were exo and endo norbornene β-amino acids.10 Diexo-N-Boc-protected 
norbornene amino ester 1 was transformed into the corresponding dihydroxy derivative 2 with N-
methylmorpholine-N-oxide (NMO) as stoichiometric co-oxidant and OsO4 as catalyst. A single 
dihydroxylated amino ester diastereomer was selectively obtained, in which the cis situation of 
the hydroxy groups relative to the methylene bridge was confirmed by NOESY experiment. 
NOE signals were observed between OH-5 (δ 4.63), OH-6 (δ 4.63) and H-7 (δ 1.81). Oxidative 
breaking of the vicinal diol C-C bond in 2 with NaIO4 gave the corresponding dialdehyde. As 
this is unstable, its solution was submitted immediately, without isolation, to reductive amination 
with benzylamine in the presence of NaBH3CN and AcOH. The ring-closure reaction afforded 
the desired azabicyclic β-amino ester 3 (Scheme 1). 
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Scheme 1. Syntheses of racemic azabicyclic β-amino ester 3. 
 
The above synthetic route was extended to the preparation of β-amino ester (+)-3 in 
enantiomerically pure form (ee > 99%) from (+)-1, synthetized by a literature method.11 Racemic 
norbornene β-lactam was subjected to enzymatic ring opening in the presence of CAL-B (lipase 
B from Candida antarctica, produced by the submerged fermentation of a genetically modified 
Aspergillus oryzae microorganism and adsorbed on a macroporous resin) in iPr2O.11 The 
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unreacted β-lactam enantiomer was transformed into the protected amino ester (+)-1 via lactam 
ring opening, followed by N-Boc protection. Further transformations (dihydroxylation, ring-
cleavage and ring-closure) were performed similarly as for the racemic substances, resulting in 
the enantiomerically pure bicyclic β-amino ester (+)-3 (Scheme 2). 
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Scheme 2. Synthesis of enantiomeric azabicyclic β-amino ester (+)-3. 
 
Via a synthetic procedure similar to that presented in Scheme 1, starting from diendo 
norbornene amino ester 4 through dihydroxylation, cleavage of the resulting diol and reductive 
amination two azabicyclic stereoisoimers 6 and the earlier synthetized 3 were obtained in a ratio 
of 9:1 (Scheme 3). The NMR data confirmed that the major product was the desired heterocyclic 
diendo amino ester 6, while the minor product was identified as the diexo compound 3 (Scheme 
3). 
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Scheme 3. Syntheses of azabicyclic β-amino esters 3, 6 and 7. 
 
The detection of 3 in this reaction mixture was somewhat surprising as it demands a 
simultaneous configuration change at two positions (Scheme 3). The explanation may be that the 
keto-enol tautomerism of the dialdehyde intermediate generated from the oxidative cleavage of 
diol 5, results in the configurational change of the heterocyclic amino ester (diendo-diexo), 
thereby accounting for the mixture of ring closure products (Scheme 4). The heterocyclic diendo 
amino ester 6 was subjected to isomerization in the presence of NaOEt in EtOH to afford a new 
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azabicyclic diastereomer 7, a C-2 epimer of 6, in good yield (77%) with almost full conversion 
(Scheme 3). 
 
 
 
Scheme 4. Possible stereoisomers of the dialdehyde intermediate due to keto-enol tautomerism. 
 
 
Experimental Section 
 
General. The chemicals were purchased from Aldrich or Fluka. The solvents were used as 
received from the supplier. NMR spectra were recorded on a Bruker DRX 400 spectrometer. 
Chemical shifts are given in δ (ppm). Optical rotations were measured with a Perkin-Elmer 341 
polarimeter. Melting points were determined with a Kofler apparatus. The mass spectra were 
recorded on a Finnigan MAT 95S spectrometer. Elemental analyses were performed with a 
Perkin-Elmer CHNS-2400 Ser II Elemental Analyzer. The ee value for (+)-3 was determined by 
HPLC on a Chiral Pak IA 5 µcolumn (0.4 cm x 1 cm) [mobile phase: n-hexane/2-propanol 
(90/10); flow rate 0.5 mL/min; detection at 205 nm; retention time (min): 16.6 (antipode: 12.7)]. 
 
General procedure for Boc protection of amino esters 
To a solution of ethyl diexo- or diendo-3-aminobicyclo[2.2.1]hept-5-ene-2-carboxylate 
hydrochloride10 (2 g, 9.23 mmol) in THF (40 mL), Et3N (1.86 g, 18.4 mmol) and di-tert-butyl 
dicarbonate (2.21 g, 10.1 mmol) were added at 0 °C. After stirring for 20 h at room temperature, 
the reaction mixture was taken up in EtOAc (40 mL) and the solution was washed with H2O (3 × 
80 mL), dried over Na2SO4 and concentrated under reduced pressure, giving amino ester 1 or 4. 
Ethyl diexo-(1S*,2S*,3R*,4R*)-3-(tert-butoxycarbonylamino)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (1). White crystals; 96% yield; mp. 141-143 °C. 1H NMR (DMSO, 400 MHz) δ: 
ISSN 1551-7012 Page 34 ©ARKAT USA, Inc. 
General Papers ARKIVOC 2010 (ix) 31-39 
1.17 (t, 3H, J = 7.05 Hz, CH3), 1.37 (s, 10H, tBu, H-7), 2.12 (d, 1H, H-7, J = 9.06 Hz), 2.45 (d, 
1H, H-2, J = 8.05 Hz), 2.54-2.60 (m, 1H, H-1), 2.83-2.87 (m, 1H, H-4), 3.77-3.81 (m, 1H, H-3), 
3.89-4.00 (m, 1H, OCH2), 4.00-4.11 (m, 1H, OCH2), 6.16-6.23 (m, 2H, H-5 and H-6), 6.63 (d, 
1H, NH, J = 8.81 Hz). 13C NMR (DMSO, 400 MHz) δ: 14.9, 27.7, 29.1, 45.1, 45.9, 48.1, 54.0, 
60.6, 78.6, 137.9, 139.7, 155.8, 173.5. Anal. Calcd for C15H23NO4: C, 64.03; H, 8.24; N, 4.98. 
Found: C, 63.91; H, 8.20; N, 4.97.  
Ethyl diendo-(1R*,2S*,3R*,4S*)-3-(tert-butoxycarbonylamino)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (4). White crystals; 83% yield; m.p. 86-88 °C. 1H NMR (DMSO, 400 MHz) δ: 1.15 
(t, 3H, J = 7.08 Hz, CH3), 1.26-1.45 (m, 11H, tBu, H-7), 2.88-2.92 (m, 1H, H-1), 2.97-3.01 (m, 
1H, H-4), 3.13-3.21 (m, 1H, H-2), 3.88-4.05 (m, 2H, OCH2), 4.38-4.49 (m, 1H, H-3), 6.62 (d, 
1H, NH, J = 8.81 Hz), 6.15-6.21 (m, 1H, H-6), 6.28-6.34 (m, 1H, H-5). 13C NMR (DMSO, 400 
MHz) δ: 14.9, 29.0, 46.5, 47.5, 47.8, 49.3, 54.5, 60.5, 78.8, 134.0, 138.7, 155.7, 172.7. Anal. 
Calcd for C15H23NO4: C, 64.03; H, 8.24; N, 4.98. Found: C, 64.00; H, 8.35; N, 5.11.  
 
General procedure for dihydroxylation of N-Boc-protected amino esters 
OsO4 (1.43 mL, 0.08 mmol; 0.06 M solution in tBuOH) was added to a stirred solution of NMO 
(1.98 mL, 9.41 mmol; 50 wt.% in H2O) and amino ester 1 or 4 (2.5 g, 8.88 mmol) in acetone (20 
mL). After 3 h, the mixture was treated with saturated aqueous Na2SO3 (25 mL) and filtered 
through Celite, and the Celite was washed with CH2Cl2 (60 mL). The phases were separated and 
the organic layer was washed with saturated aqueous NaHCO3 (2 × 25 mL), dried over Na2SO4, 
and concentrated under reduced pressure to give the crude solid, which was recrystallized from 
n-hexane/EtOAc. The oily compound was purified by column chromatography on silica gel (n-
hexane/EtOAc, 1:3). 
Ethyl diexo-(1R*,2S*,3R*,4S*)-3-(tert-butoxycarbonylamino)-5,6-dihydroxybicyclo[2.2.1]heptane-2-
carboxylate (2). White crystals; 81% yield; m.p. 116-118 °C. 1H NMR (DMSO, 400 MHz) δ: 1.14 
(t, 3H, J = 7.08 Hz, CH3), 1.35 (s, 9H, tBu), 1.61 (d, 1H, H-7, J = 10.82 Hz), 1.75-1.83 (m, 2H, 
H-7 and, H-1), 2.05-20.10 (m, 1H, H-4), 2.46-3.00 (m, 1H, H-2), 3.47-3.57 (m, 2H, H-5 and H-
6), 3.78-4.01 (m, 1H, H-3), 3.84-3.95 (m, 1H, OCH2), 3.96-4.08 (m, 1H, OCH2), 4.63 (brs, 2H, 
OH), 6.62 (d, 1H, NH, J = 8.81 Hz). 13C NMR (DMSO, 400 MHz) δ: 14.8, 29.0, 29.9, 46.5, 
49.2, 49.7, 53.0, 60.4, 71.9, 72.6, 78.5, 155.7, 172.3. MS: (ESI, pos): m/z = 338.2 (M+23). Anal. 
Calcd for C15H25NO6: C, 57.13; H, 7.99; N, 4.44. Found: C, 56.89; H, 7.80; N, 4.47. 
Ethyl diendo-(1S*,2S*,3R*,4R*)-3-(tert-butoxycarbonylamino)-5,6-dihydroxybicyclo[2.2.1]heptane-2-
carboxylate (5). White crystals; 88% yield; m.p. 86-88 °C. 1H NMR (DMSO, 400 MHz) δ: 1.13-
1.21 (m, 4H, CH3 and H-7), 1.38 (s, 9H, tBu), 1.75 (d, 1H, H-7, J = 10.32 Hz), 2.03-2.12 (m, 1H, 
H-4), 2.19-2.23 (m 1H, H-1), 2.90-2.99 (m, 1H, H-2), 3.81-4.1 (m, 5H, OCH2, H-3, H-5 and H-
6), 4.45-4.63 (m, 2H, OH), 6.63 (d, 1H, NH, J = 7.55 Hz). 13C NMR (DMSO, 400 MHz) δ: 14.9, 
29.0, 31.5, 44.2, 47.8, 49.0, 50.3, 60.8, 68.1, 69.5, 78.8, 156.0, 172.7. MS: (ESI, pos): m/z = 
339.1 (M+23). Anal. Calcd for C15H25NO6: C, 57.13; H, 7.99; N, 4.44. Found: C, 57.09; H, 8.12; 
N, 4.57. 
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General procedure for cleavage of dihydroxy compounds and ring closure with reductive 
amination 
Dihydroxy compound 2 or 5 (315 mg, 1 mmol) was dissolved in THF/H2O (11 mL, 10:1), and 
NaIO4 (0.42 g, 2 mmol) was added to the solution. After stirring for 1 h at 20 °C under an Ar 
atmosphere, H2O was added until the precipitation had dissolved. The mixture was extracted 
with CH2Cl2 (3 × 40 mL), the combined extract was dried over Na2SO4 and the resulting 
dialdehyde solution was immediately used for the next reaction without isolation. Benzylamine 
(0.11 mL, 1 mmol) and oven-dried 3 Å molecular sieve were added to the solution of the 
dialdehyde at 40 °C, which was next stirred for 10 min. A solution of NaCNBH3 (63 mg, 1 
mmol) and AcOH (0.057 mL, 1 mmol) in EtOH (2 mL) was added dropwise during 2 h under an 
Ar atmosphere. The stirring was continued for another 1 h at 40 °C. The reaction mixture was 
extracted in turn with 10% Na2CO3 (3 × 80 mL), and brine (80 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel, (3: Rf 0.35 n-hexane/EtOAc, 2:1; 6: Rf 0.35 n-hexane/EtOAc, 4:1). 
Ethyl diexo-(1R*,5R*,6S*,7R*)-3-benzyl-7-(tert-butoxycarbonylamino)-3-azabicyclo[3.2.1]octane-
6-carboxylate (3). White crystals; 36% yield (two steps); m.p. 100-103 °C. 1H NMR (DMSO, 400 
MHz) δ: 1.11-1.21 (m, 4H, CH3 and H-8), 1.36 (s, 9H, tBu), 1.95-2.02 (m, 3H, H-2, H-4, H-1), 
2.08-2.22 (m, 1H, H-8), 2.30-2.35 (m, 1H, H-5), 2.52-2.61 (m, 1H, H-4), 2.62-2.76 (m, 1H, H-2), 
3.03 (d, 1H, H-6, J = 8.31 Hz), 3.43 (s, 2H, BnCH2), 3.80-3.95 (m, 1H, OCH2), 3.96-4.09 (m, 
1H, OCH2), 4.22-4.26 (m, 1H, H-7), 6.76 (d, 1H, NH, J = 9.06 Hz), 7.20-7.38 (m, 5H, Ar-H). 
13C NMR (DMSO, 400 MHz) δ: 14.9, 29.1, 36.0, 39.4, 42.6, 53.7, 56.7, 58.5, 59.0, 60.3, 62.3, 
78.4, 127.7, 129.1, 129.4, 139.6, 155.6, 173.4. MS: (EI, pos): m/z = 388.5 (M). Anal. Calcd for 
C22H32N2O4: C, 68.01; H, 8.30; N, 7.21. Found: C, 68.17; H, 8.15; N, 7.21. 
Ethyl diendo-(1S*,5S*,6S*,7R*)-3-benzyl-7-(tert-butoxycarbonylamino)-3-azabicyclo[3.2.1]octane-
6-carboxylate (6). White crystals; 36% yield; m.p. 78-80 °C. 1H NMR (DMSO, 400 MHz) δ: 1.15 
(t, 3H, CH3 J = 7.08 Hz), 1.37 (s, 9H, tBu), 1.41-1.49 (m, 1H, H-8), 1.52-1.61 (m, 1H, H-8), 1.97 
(d, 1H, H-4, J = 10.93 Hz), 2.06-2.14 (m, 1H, H-1), 2.19 (d, 1H, H-2, J = 10.52 Hz), 2.24-2.32 
(m, 1H, H-5), 2.53-2.57 (m, 1H, H-4), 3.06 (dd, 1H, H-6, J1 = 11.14 Hz, J2 = 5.70 Hz), 3.17-3.27 
(m, 2H, BnCH2, and H-2), 3.50 (d, 1H and BnCH2, J = 12.56 Hz), 4.03 (m, 2H, OCH2), 4.15-
4.27 (m, 1H, H), 6.04 (d, 1H, NH, J = 9.92 Hz), 7.18-7.35 (m, 5H, Ar-H). 13C NMR (DMSO, 
400 MHz) δ: 14.9, 29.0, 35.9, 38.0, 47.2, 51.6, 54.8, 56.9, 60.2, 62.8, 78.3, 127,8, 129.1, 129.6, 
139.2, 156.0, 171.9. MS: (ESI, pos): m/z = 389.3 (M+1). Anal. Calcd for C22H32N2O4: C, 68.01; 
H, 8.30; N, 7.21. Found: C, 67.88; H, 8.49; N, 7.11. 
 
Isomerization of amino ester 6 
Freshly prepared NaOEt (57 mg, 0.83 mmol) was added to a solution of 6 (250 mg, 0.64 mmol) 
in anhydrous EtOH (5 mL), and the mixture was stirred at room temperature for 48 h. The 
reaction mixture was then concentrated under reduced pressure and taken up in EtOAc (15 mL), 
and the organic layer was washed with H2O (3 × 5 mL). The combined extract was dried over 
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Na2SO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (n-hexane/EtOAc, 3:1). 
Ethyl (1S*,5S*,6R*,7R*)-3-benzyl-7-(tert-butoxycarbonylamino)-3-azabicyclo[3.2.1]octane-
6-carboxylate (7). Colorless oil; 77% yield. 1H NMR (DMSO, 400 MHz) δ: 1.17 (t, 3H, CH3, J 
= 7.08 Hz), 1.32 (s, 9H, tBu), 1.36-1.39 (m, 1H, H-8), 1.62-1.72 (m, 1H, H-8), 1.96-1.99 (m, 1H, 
H-2), 2.07-2.27 (m, 3H, H-5, H-4 and H-1), 2.52-2.83 (m, 3H, H-2, H-4 and H-6), 3.35 (d, 1H, 
BnCH2, J = 12.2 Hz), 3.54 (d, 1H, BnCH2, J = 12.2 Hz), 3.98-4.14 (m, 3H, OCH2 and H-7), 5.87 
(d, 1H, NH, J = 8.08 Hz), 7.20-7.39 (m, 5H, Ar-H). 13C NMR (DMSO, 400 MHz) δ: 13.4, 27.7, 
34.1, 37.0, 38.2, 52.3, 55.2, 58.7, 59.5, 60.9, 78.0, 126.6, 128.1, 128.8, 138.0, 154.8, 174.6. Anal. 
Calcd for C22H32N2O4: C, 68.01; H, 8.30; N, 7.21. Found: C, 68.02; H, 8.46; N, 7.20. 
 
Characterization of enantiomeric compounds 
All the reactions were first optimized for racemic compounds. The 1H and 13C NMR 
spectroscopic data and elemental analyses on the enantiomeric derivatives were in accordance 
with those for the racemic compounds. Representative data on the enantiomers are as follows: 
Ethyl (1S,2S,3R,4R)-3-(tert-butoxycarbonylamino)bicyclo[2.2.1]hept-5-ene-2-carboxylate 
[(+)-1]. White crystals; 99% yield; [α]D: + 90 (c 0.245, EtOH); m.p. 101-103 °C. 
Ethyl (1R,2S,3R,4S)-3-(tert-butoxycarbonylamino)-5,6-dihydroxybicyclo[2.2.1]heptane-2-
carboxylate [(+)-2]. Yellow oil; 98% yield; [α]D: + 41 (c 0,245, EtOH). 
Ethyl (1R,5R,6S,7R)-3-benzyl-7-(tert-butoxycarbonylamino)-3-azabicyclo[3.2.1]octane-6-
carboxylate [(+)-3]. White crystals; 38% yield; [α]D: + 53 (c 0,245, EtOH); ee > 99 %; m.p. 80-
82 °C. 
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